CVS Corp (CVS) 101.90 $CVS Wal-Mart To Benefit From

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
CVS Corp (CVS) 101.90 $CVS

Wal-Mart To Benefit From Currency Risk Environment
Morgan Myrmo - at Seeking Alpha - Sat Mar 07, 8:01AM CST

TGT: 77.21 (-0.99), WMT: 82.59 (-0.98), CVS: 101.90 (-1.46), COST: 149.54 (-1.63)

Target: What Slowing Dividend Growth Means For Investors
Eli Inkrot - at Seeking Alpha - Fri Mar 06, 2:20PM CST

JPM: 60.89 (-1.11), USB: 44.67 (+0.09), TGT: 77.21 (-0.99), CVS: 101.90 (-1.46), WFC: 54.59 (-0.25)

Here’s a Reason Rite Aid (RAD) Stock Fell Today
at The Street - Thu Mar 05, 3:05PM CST
Rite Aid (RAD) stock was lower today after the company issued its same-store-sales results for February, which increased year-over-year but slowed down from January.
CVS: 101.90 (-1.46), RAD: 7.65 (-0.03)

CVS: Will Strong Dividend Growth Provide Solid Returns?
Eli Inkrot - at Seeking Alpha - Thu Mar 05, 11:14AM CST

CVS: 101.90 (-1.46)

CVS Caremark declares $0.35 dividend
Seeking Alpha - at Seeking Alpha - Wed Mar 04, 9:48AM CST

CVS: 101.90 (-1.46)

CVS Health Wins Over Analysts As Significant Growth Expected In The Next 5 Years
Equity Watch - at Seeking Alpha - Wed Mar 04, 8:17AM CST

GILD: 101.81 (-1.61), CVS: 101.90 (-1.46)

Cardinal Health Set to Buy Cordis, Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 10:26AM CST
Cardinal Health Inc. (CAH) hit a 52-week high of $90.49 on Mar 2, 2015, after the company announced plans to acquire Cordis, a unit of Johnson & Johnson (JNJ).
JNJ: 100.11 (-2.41), CAH: 87.01 (-1.94), CVS: 101.90 (-1.46), HSIC: 137.84 (-2.78)

Horizon Pharma Soars On Q4 Beat, Guidance Raise
at Investor's Business Daily - Fri Feb 27, 10:48AM CST
Specialty drugmaker Horizon Pharma (HZNP) beat analysts' Q4 expectations and raised its 2015 guidance Friday, sending its stock up 10% to a new high. Horizon's revenue in the quarter more than tripled to $103.8 million, about $8 million above...
ESRX: 82.27 (-2.01), AZN: 66.27 (-1.91), HZNP: 21.91 (+1.07), CVS: 101.90 (-1.46)

Catamaran EPS Tops, But Stock Falls On Weak Guidance
at Investor's Business Daily - Thu Feb 26, 10:59AM CST
Catamaran (CTRX) surpassed fourth-quarter earnings and sales estimates on Thursday, but shares sank on its weak full-year EPS outlook. The provider of pharmacy benefit management services saw adjusted earnings climb 19.6% to 67 cents a share in Q4,...
ESRX: 82.27 (-2.01), CTRX: 48.57 (-1.03), BRLI: 32.97 (-0.74), AAC: 29.30 (-2.80), CVS: 101.90 (-1.46), RAD: 7.65 (-0.03)

Impeccable Quality But There Are No Bargains Today In The S&P 500 Consumer Staples Sector: Part 8
Chuck Carnevale - at Seeking Alpha - Wed Feb 25, 11:00AM CST

WFM: 55.66 (-0.49), KO: 41.52 (-0.88), DPS: 78.35 (-0.55), PM: 80.05 (-1.66), AVP: 8.90 (-0.15), MKC: 73.45 (-1.28), CAG: 34.26 (-0.60), CVS: 101.90 (-1.46), COST: 149.54 (-1.63), PG: 82.66 (-1.97), GIS: 52.13 (-1.15), BF.B: 88.76 (-2.03)

Billions on the Line in the Next Drug Pricing War
Keith Speights, The Motley Fool - Motley Fool - Tue Feb 24, 7:02AM CST
Source: Gilead Sciences  One win whets the appetite for another. That certainly seems to be the case for the nation's two largest pharmacy benefits managers, Express Scripts and CVS Health . After scoring a victory in bringing hepatitis C...
ESRX: 82.27 (-2.01), GILD: 101.81 (-1.61), CVS: 101.90 (-1.46), REGN: 422.13 (-6.82)

$20 Billion Market: What’s the Best Stock to Buy?
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - Fri Feb 20, 7:01AM CST
Modern drugs, known as "biologics," are harder to develop and harder to replicate than the conventional small molecule medications we all grew up with. As a result, competitors have to work harder to develop generic approximations of them, known as...
ESRX: 82.27 (-2.01), MRK: 56.84 (-1.14), PFE: 33.97 (-0.50), MYL: 55.44 (-1.25), CVS: 101.90 (-1.46), AMGN: 154.88 (-4.72), TEVA: 56.40 (-0.11), ABBV: 55.64 (-1.22), HSP: 87.90 (+0.05), NVS: 97.46 (-1.49)

Oil Price Collapse Gives Patient Investors a Convenient Excuse to Buy
Rich Duprey, The Motley Fool - Motley Fool - Thu Feb 19, 8:02AM CST
It feels so 2008 with gas prices below $2.00 a gallon, and it creates a convenient time for investors to profit. Photo: Flickr via Minale Tattersfield. You have to go back to the depths of the Great Recession to find gasoline prices as...
MPC: 98.49 (-3.26), MCD: 97.13 (-1.98), CVS: 101.90 (-1.46), BKW: 35.50 (-1.16)

At Least Highly Rated Retailers Click With Consumers
at Investor's Business Daily - Wed Feb 18, 7:02AM CST
When it came to customer satisfaction ratings, the nation's retailers capped 2014 on a sour note. In the last quarter of 2014, customer satisfaction was down for the first time in four years, according to a report that the American Customer...
WFM: 55.66 (-0.49), AMZN: 380.09 (-7.74), HD: 114.45 (-1.46), M: 62.98 (-0.21), WMT: 82.59 (-0.98), FDO: 78.80 (+0.10), RAD: 7.65 (-0.03), NFLX: 454.12 (-13.53), LB: 90.09 (-1.14), DLTR: 79.61 (+0.18), WBA: 82.35 (-0.85), TGT: 77.21 (-0.99), CVS: 101.90 (-1.46), COST: 149.54 (-1.63), JWN: 80.86 (+0.21), DG: 71.32 (-0.39), LOW: 73.51 (-1.05)

Jim Cramer's 'Mad Money' Recap: What's Hot and Fashionable in Stocks
at The Street - Tue Feb 17, 7:26PM CST
Cyber security stocks are among those every portfolio should have, Cramer says.
LMT: 197.66 (-1.44), UNH: 112.88 (-1.91), SKX: 66.79 (-1.65), NGHC: 18.04 (-0.33), INTC: 33.19 (-0.54), PANW: 140.73 (-2.41), JACK: 96.25 (-1.30), RPTP: 10.86 (+0.09), COST: 149.54 (-1.63), LOW: 73.51 (-1.05), REGN: 422.13 (-6.82), TRV: 105.80 (-1.80), CY: 15.10 (-0.40), MU: 28.50 (-0.78), FEYE: 42.83 (-1.08), ETH: 26.49 (+0.04), BRCM: 44.33 (-0.57), VFC: 74.49 (-1.58), EW: 133.00 (-2.65), COLM: 56.19 (-0.66), SMH: 56.68 (-0.72), FIVE: 29.10 (-0.81), WM: 53.65 (-0.85), PCLN: 1,215.99 (-15.91), HAIN: 61.66 (-1.03), CVS: 101.90 (-1.46), JWN: 80.86 (+0.21), FTNT: 33.60 (-0.64)

Surprise! We Still Need Drugmakers to Develop Revolutionary Hepatitis C Drugs
Todd Campbell, The Motley Fool - Motley Fool - Tue Feb 17, 10:02AM CST
Source: Gilead Sciences. All of the market's chatter surrounding Gilead Sciences '  and AbbVie 's hepatitis C drugs this past year may have you thinking that these companies have won the decades long battle against this tough-to-treat disease....
VRTX: 126.34 (-0.62), GILD: 101.81 (-1.61), CVS: 101.90 (-1.46), ABBV: 55.64 (-1.22)

CVS Health Raises Concerns about the Potential Impact of New Class of Cholesterol Drugs on the Health Care System
PR Newswire - Tue Feb 17, 8:00AM CST
CVS Health (NYSE: CVS) weighs in on the next chapter in the debate about the impact of expensive drugs on the health care system in a commentary that appears today on the Health Affairs blog. Currently in development, PCSK9 (proprotein convertase subtilisin/kexin 9) enzyme inhibitors could successfully treat millions of Americans with high cholesterol, but at great cost to the health care system. The authors describe the real challenge is not the cost per dose, but the large eligible patient population and the duration of chronic treatment, which could span decades.
CVS: 101.90 (-1.46)

CVS Health To Present At RBC Capital Markets Healthcare Conference
PR Newswire - Mon Feb 16, 11:20AM CST
CVS Health Corporation (NYSE: CVS) today announced that Dave Denton, executive vice president and chief financial officer, will be speaking to investors at the RBC Capital Markets Healthcare Conference on February 25, 2015, at approximately 10:00 a.m. ET.
CVS: 101.90 (-1.46)

Did Rite Aid Corporation Just Ink a Super-Smart Deal?
Todd Campbell, The Motley Fool - Motley Fool - Mon Feb 16, 8:03AM CST
Source: Wiki Commons user Specious. In order to overcome headwinds from slowing sales and sky-high debt, Rite Aid has been closing stores and sweet-talking lenders for years. The pharmacy operator's recently announced acquisition of...
ESRX: 82.27 (-2.01), WBA: 82.35 (-0.85), CVS: 101.90 (-1.46), RAD: 7.65 (-0.03)

What Can 2014 Results Tell Us About The Future For CVS Health?
David Schauber, Jr. - at Seeking Alpha - Mon Feb 16, 2:09AM CST

CVS: 101.90 (-1.46)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Nevada Expands Rural Youth Mental Health Access

Updated Category News Views 171

Nevada's Rural Mental Health Crisis When you're navigating the barren stretches of rural Nevada, the scenic views can be breathtaking. But for many families, finding basic services like mental health care is as challenging as striking water in the desert. Cartwheel Care has taken the bull by the horns with their latest initiative to bridge this glaring gap. Partnering...

Continue Reading
LongueVue Capital: Betting Big on Sports & Entertainment

Updated Category News Views 90

LongueVue Capital's Bold Move You don’t always hear about private equity firms diving head-first into the sports and entertainment sector, but LongueVue Capital (LVC) is doing just that. This New Orleans-based firm is shifting its gears and setting sights on founder-owned ventures crucial to these industries. They’re asking the key question: Why focus on just the...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 25

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
AR Cards in Casino Gaming: A High-Stakes Revolution

Updated Category News Views 31

A New Breed of Casino Experience Walk into a casino today, and you might just enter a whole new reality. No, this isn’t a cheesy magician’s trick or a glitzy PR stunt—this is the real deal brought to you by augmented reality (AR) trading cards. Imagine the slots you love wrapped in a sci-fi movie where characters leap out, tap you on the shoulder, and call you by...

Continue Reading
Biel Crystal Solidifies Position as Key iPhone UTG Supplier

Updated Category News Views 95

Biel Crystal Hones In On Foldable iPhone Tech Here's the lowdown: Apple's making waves with their first foldable phone, the iPhone Duo, and Biel Crystal? They're the rockstars cranking out that ultra-thin glass making it all possible. You might not have heard their name tossed around as much, but they're heavy hitters in the tech components scene. Biel Crystal's been...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 124

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Sivers Semiconductors: Strategy Behind 2027 AGM Plans

Updated Category News Views 234

Setting the Stage for a Crucial Year Ah, the dance of corporate governance—an arena where maneuvering is an art. Sivers Semiconductors AB, a name that's becoming synonymous with innovation in the photonics and wireless solutions sector, is prepping for its 2027 Annual General Meeting. Ahead of this pivotal event, they're forming a Nomination Committee to shape future...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 39

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 148

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading
Ranger and Smith Unveil Tea-Infused Chocolate Bar

Updated Category News Views 63

Fresh Collaborations in Portland's Culinary Scene Ah, the sweet crossover in Portland's food scene is once again in the spotlight with a new entry that's sure to titillate taste buds. Ranger Chocolate Co. and Steven Smith Teamaker are at it again, rolling out a delectable creation that merges the poetic elegance of tea with the indulgent richness of chocolate. Welcome,...

Continue Reading

Top 5 Most Recently Viewed Articles

Algeness® VL Filler Receives Marketing Approval in China

Updated Category News Views 273

Exciting Developments for Advanced Aesthetic Technologies Advanced Aesthetic Technologies, Inc. (AAT) recently celebrated a significant milestone with the approval of their Algeness® VL agarose facial injection filler for marketing in China. This landmark achievement opens up new avenues for AAT in expanding their product offerings in the Asian market and showcases their...

Continue Reading
Criminal Charges Anticipated in Trump Campaign Hacking Case

Updated Category News Views 154

Criminal Charges Expected in Trump Campaign Hacking Case U.S. authorities are preparing to file criminal charges regarding an incident in which the Trump campaign claimed its internal communications were hacked, allegedly by the Iranian government. This concerning situation has drawn the attention of both the public and officials, raising serious issues surrounding...

Continue Reading
Semler Scientific Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 187

Semler Scientific and the Class Action Lawsuit Overview In recent news, a class action lawsuit has taken center stage involving Semler Scientific, Inc. (SMLR). Investors who have experienced losses related to their investments in Semler are advised to take note of this development, which may directly impact their financial outcomes. Understanding the Lawsuit This class...

Continue Reading
FTC Solar Engages Investors at Key Industry Conferences

Updated Category News Views 159

FTC Solar Engages Investors at Key Industry Conferences FTC Solar, Inc. (Nasdaq: FTCI), an innovative leader in solar tracker systems and engineering services, is set to make significant strides in connecting with investors at three prominent conferences. These events provide a platform for the management team, including CEO Yann Brandt, to engage in discussions that...

Continue Reading
Anixa Biosciences Set to Share Innovations in Cancer Therapy

Updated Category News Views 88

Anixa Biosciences Set to Conduct a Notable Presentation Anixa Biosciences, Inc. (NASDAQ: ANIX), a leading biotechnology firm dedicated to the treatment and prevention of cancer, has taken a significant step forward by announcing its participation in a prestigious investment conference. This event, the H.C. Wainwright 27th Annual Global Investment Conference, promises to...

Continue Reading